LaneLabs USA, Allendale, NJ, has signed a marketing agreement with USV Limited of India. USV is one of India’s largest pharmaceutical companies, specializing in multivitamins and diabetes and cardiovascular drugs. USV begins the marketing agreement with the launch of LaneLabs’ advanced calcium complex, which is available in the U.S. as AdvaCAL. USV will market AdvaCAL in India as TripleACAL, offering USV the opportunity to enter the osteoporosis prevention market in India.